Even in cases of negative preoperative imaging, including negative GLP-1R PET/CT, the available literature suggests that minimally invasive exploration with endoscopic ultrasound is feasible and safe if patients display persisting symptoms indicative of an insulinoma. This evidence concerns the gene GLP1R and pancreatic insulinoma.